Treatment of acute myelogenous leukemia in patients more than 80 years old

Japanese Journal of Cancer and Chemotherapy

Volumn 24, Issue 9, 1997, Pages 1089-1093

  Takeyama, H ^a   Yamamoto, Y ^a   Yamada, H ^a   Watanabe, E ^a   Aoki, H ^a   Iinuma, M ^a  

^a Dept of Internal Medicine   (Japan)

Author keywords

Elderly AML; QOL; Treatment

Indexed keywords

BESTATIN; CYTARABINE; DAUNORUBICIN; MERCAPTOPURINE; PREDNISOLONE;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CLINICAL ARTICLE; CORONARY RISK; FEMALE; HUMAN; LEUKOCYTE COUNT; MALE; RISK ASSESSMENT; SECOND CANCER;

6-MERCAPTOPURINE; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTARABINE; DAUNORUBICIN; FEMALE; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; PREDNISOLONE; QUALITY OF LIFE; REMISSION INDUCTION;

EID: 0030886469     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)